MedPath

The Effectiveness of Neurodynamic Mobilization in Carpal Tunnel Syndrome

Not Applicable
Not yet recruiting
Conditions
Carpal Tunnel Syndrome (CTS)
Median Nerve
Registration Number
NCT06882707
Lead Sponsor
Kutahya Health Sciences University
Brief Summary

This randomized, clinical, single-blinded, controlled study will initially planned to include 86 patients diagnosed with carpal tunnel syndrome who applied to Kütahya Health Sciences University, Evliya Çelebi Training and Research Hospital, Physical Medicine and Rehabilitation outpatient clinic and Kutahya City Hospital.Patients aged 20-55 years who were diagnosed with mild and moderate carpal tunnel syndrome by electromyography (EMG) in the last 6 months were included in the study. The patients were randomized into two groups using the computer-assisted randomization method. Median nerve mobilization and ultrasound therapy will be given to the study group, and only ultrasound therapy will be given to the control group. All the patients were evaluated with the Visual Analog Scale (VAS), Hand and Pinching Grip Test, Boston Carpal Tunnel Questionnaire (BCTQ) and Median Nerve and Abductor Pollicis Brevis Muscle ultrasonography before the intervention and at the third week of intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Diagnosed with mild-to-moderate CTS on the dominant hand, based on the electrodiagnostic examination.
  • Aged 20-55 years.
  • Consent to receive the described treatment.
  • Lasting symptoms at least 3 months
Exclusion Criteria
  • A systemic inflammatory disease.
  • Any disease that can cause polyneuropathy, for example, diabetes mellitus.
  • A cognitive disorder.
  • Receiving psychotherapy.
  • A pacemaker.
  • Any disease that can affect the central nervous system.
  • Carpal tunnel syndrome surgery history

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Ultrasound assessmentChange from Baseline at 3th weeks

The Median nerve's diameter will be evaluated bilaterally by another researcher blinded to interventions and experienced in musculoskeletal ultrasonography, using ultrasound with a 6-18 Mhz linear probe (Mindray-UMT 200, USA).

During the examination, patients will be seated on a stretcher, while the examiner sat on a higher stool.

The Median nerve will be evaluated by measuring the circumference of the nerve at the location where the nerve entered the carpal tunnel.

The ultrasound probe will be positioned above the epicondylus lateralis. The nerve cross-sectional area (CSA) will be recorded in the carpal tunnel while it was perpendicular to the wrist at 90 degrees on the Median nerve trace.

The nerve diameter will be measured from the circumference of the epineurium.

Secondary Outcome Measures
NameTimeMethod
Hand and pinching grip measurementChange from Baseline at 3th weeks

The grip strength of the hand is measured with the Jamar hand dynamometer recommended by the American Association of Hand Therapists (AETD).

The measurement will be performed in the standard position specified by the AETD; the patient will be seated, shoulders in adduction and neutral rotation, elbow in 90 degree flexion, forearm in mid-rotation and supported, wrist in neutral position with three repetitions and the results will be recorded in kilograms.

Pinch force will be measured in the same position as the hand grip strength is measured with a pincmeter.

It will be evaluated in two different positions, lateral and triple grip. When evaluating the lateral grip, the patient will be asked to press the pinchmeter from the top with the middle of the distal phalanx of the thumb and support the lower part of the pinchmeter with the second phalanx of the index finger.

When evaluating the triple grip, measurements will be made by squeezing the thumb on one side of the pinchmeter an

Symptom severity and functional statusChange from Baseline at 3th weeks

Symptom severity and functional status were evaluated with BCTQ, a self-report measure of CTS with two domains: the Boston Carpal Tunnel Syndrome Questionnaire Symptom severity scale comprising 11 items to evaluate pain, paresthesia, and weakness and the Boston Carpal Tunnel Syndrome Questionnaire Symptom functional status domain with eight items assessing the ability to perform hand-related activities.

For each item, a high score indicates an increasing severity of symptoms or difficulty experienced.

The validity and reliability analyses of the Turkish version of BCTQ were undertaken by Sezgin et al19 Reliability of the Turkish version was very good, with high internal consistency (Cronbach's alpha 0.82 for symptom severity scale, and 0.88 for functional status scale), and reproducibility (Pearson correlation coefficient 0.60 for symptom severity scale, and 0.77 for functional status scale).

Trial Locations

Locations (1)

Kutahya Health Sciences University

🇹🇷

Kutahya, Turkey

Kutahya Health Sciences University
🇹🇷Kutahya, Turkey
Dilan Ozkaya BULUT, MD
Contact
02742654300
dilan.bulut1301@gmail.com
Dilan Bulut OZKAYA, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.